Medtech

Medical technology startup Carcinotech has raised £4.2 million of funding as the company looks to build on its traction in the UK and Europe, with US expansion planned later this year.

Five University of Edinburgh companies and academics have been announced as 2024 finalists in Scotland’s Life Sciences Awards.

A team of scientists has developed a new blood test that can monitor the progression of cancer in dogs.

3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests.

A novel 3D printed device that could replace the need for drug and chemical safety testing on animals has received new funding.

Scotland is set to receive its first total-body scanner in a boost to clinical research that aims to improve the detection, diagnosis and treatment of complex, multi-organ diseases.

Bio-magnetic sensor technology company Neuranics, a joint spinout from the Universities of Glasgow and Edinburgh, has secured £1.9m investment in a pre-seed round that included Old College Capital, the University of Edinburgh’s venture investment fund.

New spinout AlveoGene, focused on transforming rare respiratory disease outcomes using inhaled gene therapy, has launched out of the Universities of Oxford and Edinburgh and Imperial College London.